SARAH GATTIS: Open Payments
NPI 1497472815 · EVERETT, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$240 in 10 payments from 5 companies in 2025. Trend: 2023 $51 · 2024 $76 · 2025 $240
Food & beverage: $240
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 5 | $105 |
| Novo Nordisk Inc | 2 | $44 |
| GlaxoSmithKline, LLC. | 1 | $34 |
| Amgen Inc. | 1 | $30 |
| Merck Sharp & Dohme LLC | 1 | $28 |
Products named: PREVNAR 20, SHINGRIX, OTEZLA, M-M-R II, Ozempic, ELIQUIS.
Industry payments across WA — which companies pay providers there.
